Mirabella Financial Services’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.04M | Buy |
3,750,000
+10,049
| +0.3% | +$24.2K | 0.93% | 24 |
|
|
2025
Q1 | $8.27M | Buy |
+3,739,951
| New | +$8.27M | 0.33% | 56 |
|
|
2022
Q4 | – | Sell |
-39,964
| Closed | -$1.02M | – | 470 |
|
|
2022
Q3 | $1.02M | Buy |
+39,964
| New | +$1.02M | 0.11% | 110 |
|
|
2022
Q2 | – | Sell |
-35,439
| Closed | -$1.25M | – | 626 |
|
|
2022
Q1 | $1.25M | Buy |
+35,439
| New | +$1.25M | 0.14% | 136 |
|
|
2021
Q4 | – | Sell |
-60,645
| Closed | -$2.98M | – | 541 |
|
|
2021
Q3 | $2.98M | Buy |
60,645
+26,073
| +75% | +$1.28M | 0.39% | 68 |
|
|
2021
Q2 | $1.44M | Buy |
34,572
+16,835
| +95% | +$703K | 0.26% | 107 |
|
|
2021
Q1 | $632K | Sell |
17,737
-3,403
| -16% | -$121K | 0.2% | 112 |
|
|
2020
Q4 | $593K | Buy |
+21,140
| New | +$593K | 0.07% | 161 |
|